openPR Logo
Press release

Neuralia TMS Delivers Advanced TMS Therapy for OCD Treatment

03-17-2026 12:50 PM CET | Health & Medicine

Press release from: King Newswire

Neuralia TMS Delivers Advanced TMS Therapy for OCD Treatment

Australia, 17th Mar 2026 - Neuralia TMS, a leader in non-invasive neurological treatments, has announced an expansion of its services to include transcranial Direct Current Stimulation (tDCS), an at-home neuromodulation therapy, as well as pharmacogenetic testing to optimise treatment outcomes. Known for its expertise in Transcranial Magnetic Stimulation (TMS) therapy, Neuralia TMS continues to provide evidence-based, drug-free treatments for individuals experiencing conditions such as depression, anxiety, PTSD, obsessive-compulsive disorder (OCD), chronic pain, and Parkinsons disease.

Dr Shanek Wick, Medical Director at Neuralia TMS, provided insight into the company's latest offerings: The integration of transcranial Direct Current Stimulation (tDCS) into the treatment portfolio reflects a commitment to exploring advanced, personalised approaches to neuromodulation therapy. tDCS provides patients with a flexible, at-home option that complements the clinical applications of TMS therapy, contributing to enhanced mental health and overall wellness.

TMS therapy, a proven method for treating conditions like depression, is a cornerstone of Neuralia TMS's services. The addition of tDCS expands the available treatment options, responding to growing demand for non-invasive and patient-centred therapies. tDCS works by applying a low electrical current to targeted brain areas, helping to modulate brain activity and support mental well-being. Unlike TMS, which is administered in a clinical setting, tDCS offers patients the convenience of managing their treatment from home, thereby broadening the accessibility of these therapies.

Pharmacogenetic testing is another important development within Neuralia TMSs comprehensive treatment approach. By analysing patients genetic profiles, healthcare providers can tailor treatments to meet individual needs. This personalised strategy enhances the likelihood of positive therapeutic responses while minimising the potential for adverse side effects.

Dr Wick shared further thoughts on the future direction of the company: As the field of neuromodulation continues to evolve, Neuralia TMS remains focused on staying at the forefront of emerging technologies. The organisation is committed to exploring innovative methods that can further improve patient care, with an emphasis on expanding access to non-invasive treatments and making personalised care a standard practice in mental health and neurological therapy.

Neuralia TMS has long been recognised for its dedication to delivering high-quality care. Its multidisciplinary team works closely with patients to create individualised treatment plans that address the full spectrum of mental health and neurological challenges. The recent integration of tDCS and pharmacogenetic testing further establishes Neuralia TMS as a leader in the field, providing patients with a more extensive range of options for managing both mental health and neurological disorders.

These advancements reflect Neuralia TMS's mission to offer a patient-centred approach to mental health care. By utilising the latest developments in non-invasive therapies, Neuralia TMS continues to improve the quality of life for individuals facing complex conditions.

For additional information about Neuralia TMS and its services, including TMS for OCD, or to schedule a consultation, individuals can contact Neuralia TMS directly. The clinic can be reached by phone at 03 6230 3996 or via email at info@neuralia.com.au. Neuralia TMS is dedicated to providing advanced TMS treatments tailored to address various conditions, including obsessive-compulsive disorder (OCD).

Contact Details

Organization: Neuralia TMS

Contact Person: Dr Shanek Wick

Website: https://www.neuraliatms.com.au/

Email: Send Email [https://dashboard.kingnewswire.com/release-contact/42691]

Contact Number: +61862303996

Country: Australia

Release Id: 17032642691

The post Neuralia TMS Delivers Advanced TMS Therapy for OCD Treatment appeared first on King Newswire. This content is provided by a third-party source. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the 'Media Contact' section above.

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. king Newswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact support@kingnewswire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuralia TMS Delivers Advanced TMS Therapy for OCD Treatment here

News-ID: 4427869 • Views:

More Releases from King Newswire

New Guide Helps Musicians Create a Connected Music Marketing System
New Guide Helps Musicians Create a Connected Music Marketing System
Content Marketing for Independent Musicians in 2026 offers practical strategies, campaign ideas, prompts, platform guidance, and promotional tools for artists building careers without major-label support. United States, 11th Jul 2026 -- Independent musicians have more ways to release and promote music than ever, but managing those options can quickly become overwhelming. A new guide, Content Marketing for Independent Musicians in 2026: How to Turn Songs, Stories, Videos, and Shows Into a
LobsterAnywhere Shares Culinary Insight for the Summer Season: Lobsters Should Be Grilled, Not Boiled
LobsterAnywhere Shares Culinary Insight for the Summer Season: Lobsters Should B …
With beef prices running high and Maine lobster in peak season, LobsterAnywhere says whole lobster and lobster tails deserve real estate on the grill grate this summer. Amesbury, MA, United States, 10th Jul 2026 -- LobsterAnywhere.com, the supplier of Maine lobster and seafood nationwide since 1999, today shared culinary guidance for consumers this summer, saying that lobsters should be grilled, rather than boiled. Grilling results in better flavor, while enabling consumers
Selling Your Business Why More Owners Are Choosing Direct Buyers Instead of Traditional Brokers
Selling Your Business Why More Owners Are Choosing Direct Buyers Instead of Trad …
United States, 11th Jul 2026 - For many entrepreneurs, selling a business is one of the most significant financial decisions they will ever make. Years of hard work, long hours, personal sacrifice, and financial investment have gone into building a successful company. Whether the goal is retirement, pursuing a new opportunity, succession planning, or simply enjoying the next chapter of life, choosing the right buyer can have a lasting impact
Northlake Concierge Medical Center Announces Boutique Class-A Medical Office Development in Tucker, Georgia
Northlake Concierge Medical Center Announces Boutique Class-A Medical Office Dev …
A New Vision for Physician-Owned Healthcare, Concierge Medicine, and Modern Outpatient Medical Services in Metro Atlanta's Growing Northlake Corridor United States, 11th Jul 2026 - Vice Holdings LLC today announced the development of Northlake Concierge Medical Center, a boutique Class-A medical office destination planned for 2054 Harobi Drive, Tucker, Georgia. The project represents the transformation of an existing commercial property into a modern physician-focused healthcare environment designed specifically for concierge medicine,

All 5 Releases


More Releases for TMS

Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision. Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure
Neuralia TMS Broadens Access to Non-Invasive TMS Treatment for Depression
Australia, 27th Jan 2026 - Neuralia TMS, a respected provider of non-invasive neuromodulation therapies, has announced an expansion of access to Transcranial Magnetic Stimulation treatment for individuals living with depression, reflecting continued developments in evidence-based mental health care and increasing demand for non-pharmacological treatment options. The expanded availability is intended to support patients seeking additional clinical pathways under medical supervision. Transcranial Magnetic Stimulation, commonly known as TMS, is a non-invasive procedure
Neuralia TMS Opens Doors in Melbourne to Meet Rising Demand for TMS Treatment Ac …
Australia, 17th Dec 2025 - Neuralia TMS, a leader in Transcranial Magnetic Stimulation (TMS) therapy, has officially opened a new clinic in Moonee Ponds to address the increasing demand for alternative treatments for mental health and chronic pain. The new facility offers non-invasive TMS therapy to treat conditions such as depression, anxiety, and chronic pain by using magnetic pulses to stimulate specific areas of the brain, providing patients with an
Neuralia TMS Provides Proven TMS Therapy to Help Manage Depression
Australia, 19th Nov 2025 - Neuralia TMS, a respected provider of neuromodulation treatments in Melbourne's inner north, has reaffirmed its commitment to delivering evidence-supported Transcranial Magnetic Stimulation (TMS) therapy for individuals experiencing treatment-resistant depression. The clinic, located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC, continues to operate as a treatment centre offering structured, non-invasive therapeutic programs grounded in current clinical research. TMS therapy has become an established component
TMS (Transcranial Magnetic Stimulation) Coil Market Analysis By Manufacturers - …
The TMS (Transcranial Magnetic Stimulation) Coil Market Research Report Forecasts 2019-2025 is a valuable source of insightful data for business strategists. This TMS (Transcranial Magnetic Stimulation) Coil Market study provides comprehensive data on aspects of competitive intelligence, market research, strategy, planning, pricing and forecasting that enhances the understanding, scope, and application of this report. According to this study, over the next five years, the TMS (Transcranial Magnetic Stimulation) Coil market will
TMS celebrates 50 not out
Dubai, 15th June 2016:- This is the 50th edition of the TMS Newsletter and The Maritime Standard would like to thank all its readers for their support in helping reach this significant milestone. Clive Woodbridge, editor, says, “We are very grateful for the encouragement and positive feedback that our readers have given us. It is our aim to continue to improve the newsletter and we look forward to expanding and enhancing